Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? (Q35894626)
Jump to navigation
Jump to search
scientific article published in October 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? |
scientific article published in October 2004 |
Statements
1 reference
Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? (English)
1 reference
Michael A Pulsipher
1 reference
1 October 2004
1 reference
1 reference
43
1 reference
5
1 reference
523-533
1 reference
Identifiers
1 reference
1 reference